179 related articles for article (PubMed ID: 33172596)
1. Novel molecular targets in gastric adenocarcinoma.
Ramezankhani R; Solhi R; Es HA; Vosough M; Hassan M
Pharmacol Ther; 2021 Apr; 220():107714. PubMed ID: 33172596
[TBL] [Abstract][Full Text] [Related]
2. Synergistic triad epistasis of epigenetic H3K27me modifier genes, EZH2, KDM6A, and KDM6B, in gastric cancer susceptibility.
Lee SW; Park DY; Kim MY; Kang C
Gastric Cancer; 2019 May; 22(3):640-644. PubMed ID: 30374835
[TBL] [Abstract][Full Text] [Related]
3. Fluctuations of epigenetic regulations in human gastric Adenocarcinoma: How does it affect?
Samadani AA; Noroollahi SE; Mansour-Ghanaei F; Rashidy-Pour A; Joukar F; Bandegi AR
Biomed Pharmacother; 2019 Jan; 109():144-156. PubMed ID: 30396071
[TBL] [Abstract][Full Text] [Related]
4. DNA and histone methylation in gastric carcinogenesis.
Calcagno DQ; Gigek CO; Chen ES; Burbano RR; Smith Mde A
World J Gastroenterol; 2013 Feb; 19(8):1182-92. PubMed ID: 23482412
[TBL] [Abstract][Full Text] [Related]
5. An updated review of gastric cancer in the next-generation sequencing era: insights from bench to bedside and vice versa.
Yamamoto H; Watanabe Y; Maehata T; Morita R; Yoshida Y; Oikawa R; Ishigooka S; Ozawa S; Matsuo Y; Hosoya K; Yamashita M; Taniguchi H; Nosho K; Suzuki H; Yasuda H; Shinomura Y; Itoh F
World J Gastroenterol; 2014 Apr; 20(14):3927-37. PubMed ID: 24744582
[TBL] [Abstract][Full Text] [Related]
6. Identification of putative drugs for gastric adenocarcinoma utilizing differentially expressed genes and connectivity map.
Chen ZX; Zou XP; Yan HQ; Zhang R; Pang JS; Qin XG; He RQ; Ma J; Feng ZB; Chen G; Gan TQ
Mol Med Rep; 2019 Feb; 19(2):1004-1015. PubMed ID: 30569111
[TBL] [Abstract][Full Text] [Related]
7. EZH2 and KDM6A act as an epigenetic switch to regulate mesenchymal stem cell lineage specification.
Hemming S; Cakouros D; Isenmann S; Cooper L; Menicanin D; Zannettino A; Gronthos S
Stem Cells; 2014 Mar; 32(3):802-15. PubMed ID: 24123378
[TBL] [Abstract][Full Text] [Related]
8. Gastric Adenocarcinoma: An Update on Genomics, Immune System Modulations, and Targeted Therapy.
Lee J; Bass AJ; Ajani JA
Am Soc Clin Oncol Educ Book; 2016; 35():104-11. PubMed ID: 27249691
[TBL] [Abstract][Full Text] [Related]
9. Epigenetics: an emerging player in gastric cancer.
Kang C; Song JJ; Lee J; Kim MY
World J Gastroenterol; 2014 Jun; 20(21):6433-47. PubMed ID: 24914365
[TBL] [Abstract][Full Text] [Related]
10. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
11. Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes.
Zang ZJ; Cutcutache I; Poon SL; Zhang SL; McPherson JR; Tao J; Rajasegaran V; Heng HL; Deng N; Gan A; Lim KH; Ong CK; Huang D; Chin SY; Tan IB; Ng CC; Yu W; Wu Y; Lee M; Wu J; Poh D; Wan WK; Rha SY; So J; Salto-Tellez M; Yeoh KG; Wong WK; Zhu YJ; Futreal PA; Pang B; Ruan Y; Hillmer AM; Bertrand D; Nagarajan N; Rozen S; Teh BT; Tan P
Nat Genet; 2012 May; 44(5):570-4. PubMed ID: 22484628
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic regulation of GATA4 expression by histone modification in AFP-producing gastric adenocarcinoma.
Yamamura N; Kishimoto T
Exp Mol Pathol; 2012 Aug; 93(1):35-9. PubMed ID: 22472323
[TBL] [Abstract][Full Text] [Related]
13. Cancer type-specific epigenetic changes: gastric cancer.
Calcagno DQ; de Arruda Cardoso Smith M; Burbano RR
Methods Mol Biol; 2015; 1238():79-101. PubMed ID: 25421656
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic Mechanisms and Events in Gastric Cancer-Emerging Novel Biomarkers.
Puneet ; Kazmi HR; Kumari S; Tiwari S; Khanna A; Narayan G
Pathol Oncol Res; 2018 Oct; 24(4):757-770. PubMed ID: 29552712
[TBL] [Abstract][Full Text] [Related]
15. Advanced gastric adenocarcinoma: optimizing therapy options.
Mizrak Kaya D; Harada K; Shimodaira Y; Amlashi FG; Lin Q; Ajani JA
Expert Rev Clin Pharmacol; 2017 Mar; 10(3):263-271. PubMed ID: 28094573
[TBL] [Abstract][Full Text] [Related]
16. Phase I Study of Epigenetic Priming with Azacitidine Prior to Standard Neoadjuvant Chemotherapy for Patients with Resectable Gastric and Esophageal Adenocarcinoma: Evidence of Tumor Hypomethylation as an Indicator of Major Histopathologic Response.
Schneider BJ; Shah MA; Klute K; Ocean A; Popa E; Altorki N; Lieberman M; Schreiner A; Yantiss R; Christos PJ; Palmer R; You D; Viale A; Kermani P; Scandura JM
Clin Cancer Res; 2017 Jun; 23(11):2673-2680. PubMed ID: 27836862
[No Abstract] [Full Text] [Related]
17. Selective sensitivity of EZH2 inhibitors based on synthetic lethality in ARID1A-deficient gastric cancer.
Yamada L; Saito M; Thar Min AK; Saito K; Ashizawa M; Kase K; Nakajima S; Onozawa H; Okayama H; Endo H; Fujita S; Sakamoto W; Saze Z; Momma T; Mimura K; Ohki S; Kono K
Gastric Cancer; 2021 Jan; 24(1):60-71. PubMed ID: 32506298
[TBL] [Abstract][Full Text] [Related]
18. [Promoter methylation of several tumor suppressor genes in human gastric adenocarcinoma].
Cai JC; Liu D; Zhang HP; Zhong S; Xia NS
Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(14):978-81. PubMed ID: 17650424
[TBL] [Abstract][Full Text] [Related]
19. Loss of tumor suppressor KDM6A amplifies PRC2-regulated transcriptional repression in bladder cancer and can be targeted through inhibition of EZH2.
Ler LD; Ghosh S; Chai X; Thike AA; Heng HL; Siew EY; Dey S; Koh LK; Lim JQ; Lim WK; Myint SS; Loh JL; Ong P; Sam XX; Huang D; Lim T; Tan PH; Nagarajan S; Cheng CW; Ho H; Ng LG; Yuen J; Lin PH; Chuang CK; Chang YH; Weng WH; Rozen SG; Tan P; Creasy CL; Pang ST; McCabe MT; Poon SL; Teh BT
Sci Transl Med; 2017 Feb; 9(378):. PubMed ID: 28228601
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic inactivation of deleted in lung and esophageal cancer 1 gene by promoter methylation in gastric and colorectal adenocarcinoma.
Zhang Y; Ye X; Geng J; Chen L
Hepatogastroenterology; 2010; 57(104):1614-9. PubMed ID: 21443130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]